A research Consortium to define the function of MeCP2: A step towards the development of therapeutics for treating Rett Syndrome

Reference: Adrian Bird Abstract: n.a PROJECT DETAILS  beginning: 2011. end: 2014. Country of research: United Kingdom Counry of funding source: United States Funding organization: Rett Syndrome Research Trust Financing: PRIVATE FUNDERS – 442 254 € hyperlink

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close